invigorating 发表于 2025-3-21 16:30:38

书目名称International Conference on Artificial Intelligence and Sustainable Engineering影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0471371<br><br>        <br><br>书目名称International Conference on Artificial Intelligence and Sustainable Engineering读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0471371<br><br>        <br><br>

冒号 发表于 2025-3-21 22:01:41

http://reply.papertrans.cn/48/4714/471371/471371_2.png

Introduction 发表于 2025-3-22 04:10:39

http://reply.papertrans.cn/48/4714/471371/471371_3.png

脆弱带来 发表于 2025-3-22 04:42:51

Pooja Maindarkar,S. Sofana Reka are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: „Me

Pantry 发表于 2025-3-22 10:08:48

http://reply.papertrans.cn/48/4714/471371/471371_5.png

geometrician 发表于 2025-3-22 13:36:53

Saba Farheen Munshi,Chandrakant P. Navdeti are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: „Me

免费 发表于 2025-3-22 19:40:16

http://reply.papertrans.cn/48/4714/471371/471371_7.png

Concomitant 发表于 2025-3-23 01:08:10

http://reply.papertrans.cn/48/4714/471371/471371_8.png

Abrupt 发表于 2025-3-23 02:34:46

http://reply.papertrans.cn/48/4714/471371/471371_9.png

易弯曲 发表于 2025-3-23 08:53:10

http://reply.papertrans.cn/48/4714/471371/471371_10.png
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: International Conference on Artificial Intelligence and Sustainable Engineering; Select Proceedings o Goutam Sanyal,Carlos M. Travieso-Gonz